Reported Saturday, vTv Research Estimates 54% Of Adults On Automated Insulin Delivery Face Hypoglycemia Burden, As Company Advances Oral Cadisegliatin For Type 1 Diabetes

뉴스 본문을 불러오고 있어요.

Reported Saturday, vTv Research Estimates 54% Of Adults On Automated Insulin Delivery Face Hypoglycemia Burden, As Company Advances Oral Cadisegliatin For Type 1 Diabetes | 웨이프 WAPE

Reported Saturday, vTv Research Estimates 54% Of Adults On Automated Insulin Delivery Face Hypoglycemia Burden, As Company Advances Oral Cadisegliatin For Type 1 Diabetes

기사 요약

관련 종목

웨이프 AI가 분석했어요.

vTv Therapeutics가 제1형 당뇨병 치료제 개발을 진전시키고 있습니다.

댓글 —